Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
Sign Up to like & getrecommendations! Published in 2023 at "Europace"
DOI: 10.1093/europace/euad122.515
Abstract: Abstract Funding Acknowledgements Type of funding sources: None. Background Hypertrophic cardiomyopathy (HCM) is a recognized cause of sudden cardiac death and dysrhythmias. Patients with HCM and marked left ventricular outflow tract obstruction (LVOTO) may benefit… read more here.
Keywords: reduction therapies; myectomy; septal myectomy; septal reduction ... See more keywords
Abstract 4139079: Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4139079
Abstract: Background: Septal myectomy (SM) and alcohol septal ablation (ASA) are preferred modalities for individuals with symptomatic obstructive hypertrophic cardiomyopathy (HCM). Apart from patient-level factors, operator and hospital volume play a role in determining clinical outcomes… read more here.
Keywords: septal reduction; volume operators; reduction therapies; compared high ... See more keywords